Skip to content
Recall Observatory FDA recall evidence

Drug product

Zileuton Extended-Release Tablets, 600 mg, 120-count bottle, Rx only, Manufactured for Lupin Pharmaceuticals, Inc., Baltimore, MD 21202 by Lupin Limited, Nagpur-441108, India, NDC 68180-169-16

D-1150-2022

June 10, 2022

Class II

Product summary

Firm
Lupin Pharmaceuticals Inc.
Event
Event 90415
Status
Terminated
Classification
Class II
Quantity
3,216 bottles
Official record key
drug-enforcement:D-1150-2022

Official wording

Reason: Failed Dissolution Specifications: Out of specification test results observed in dissolution testing during long term stability study.

Code information: Lots: M100070, M100239, Exp. 06/22, M100312, Exp.09/22, M100366, Exp.10/22

Distribution pattern: Product was distributed to 10 wholesalers/distributors and one mail order account who may have further distributed the product nationwide.

Derived failure modes

  • Potency or specification failure

    reason.potency_specification_failure · v1.0.0

    Out of specification